AXIL CAPITAL
Axil Capital is a venture capital firm investing in companies in the biomedical and healthcare fields from the early stages.
AXIL CAPITAL
Industry:
Artificial Intelligence Pharmaceutical Robotics Venture Capital
Founded:
2017-01-01
Status:
Active
Contact:
03-3527-2212
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Google Apps For Business
Similar Organizations
BioVenture
BioVenture is a Chinese venture capital firm that offers early and growth stage investment services.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Current Employees Featured
Hiroshi Gonaikawa
Hiroshi Gonaikawa Co-Founder & Partner @ Axil Capital Co-Founder & Partner
Fred Shane
Fred Shane Managing Partner & Co-Founder @ Axil Capital Managing Partner & Co-Founder
Founder
Fred Shane
Hiroshi Gonaikawa
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-11 | AIBIOS | Axil Capital investment in Seed Round - AIBIOS | 770 M JPY |
2021-03-29 | Suono Bio | Axil Capital investment in Series A - Suono Bio | N/A |
2021-03-03 | TechsoMed | Axil Capital investment in Series B - TechsoMed | 7 M USD |
2021-01-20 | JOLLY GOOD | Axil Capital investment in Venture Round - JOLLY GOOD | 1.2 B JPY |
2020-12-08 | United Immunity | Axil Capital investment in Corporate Round - United Immunity | 70 M JPY |
2020-11-10 | Perseus Proteomics | Axil Capital investment in Venture Round - Perseus Proteomics | 860 M JPY |
2020-09-01 | LUCA Science | Axil Capital investment in Series A - LUCA Science | 9.8 M USD |
2020-06-16 | C4 Therapeutics | Axil Capital investment in Series B - C4 Therapeutics | N/A |
2019-07-25 | JOLLY GOOD | Axil Capital investment in Series B - JOLLY GOOD | 100 M JPY |
2019-07-23 | Frequency Therapeutics | Axil Capital investment in Series C - Frequency Therapeutics | N/A |